Related Experiment Video
Updated: Aug 17, 2026
Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
Central and peripheral components of cardiac failure
Insights
Chronic heart failure involves silent myocardial damage and later congestive symptoms. Current treatments manage symptoms but future therapies aim to halt or reverse the underlying myocardial failure for better outcomes.
Area of Science:
- Cardiology
- Heart Failure Pathophysiology
Background:
- Chronic heart failure (CHF) arises from myocardial and congestive failure processes.
- Myocardial failure is often silent, characterized by reduced left ventricular ejection fraction.
- Etiologic factors include overload, ischemia, necrosis, and microvascular spasm.
Purpose of the Study:
- To elucidate the two-stage progression of chronic heart failure.
- To highlight the limitations of current therapies in addressing myocardial failure.
- To emphasize the need for early intervention to modify myocardial failure.
Main Methods:
- Review of established pathophysiology of chronic heart failure.
- Analysis of clinical presentation and diagnostic markers (e.g., ejection fraction, maximal oxygen uptake).
- Evaluation of current therapeutic strategies and their impact on myocardial versus congestive failure.
Main Results:
- Myocardial failure precedes congestive heart failure and is clinically silent.
- Congestive heart failure, marked by peripheral circulation derangements, indicates a poor prognosis.
- Maximal oxygen uptake objectively assesses CHF severity.
- Current therapies alleviate symptoms of congestive failure but do not affect the primary myocardial issue.
Conclusions:
- CHF progresses from silent myocardial damage to symptomatic congestive failure.
- Effective future therapies must target the early myocardial process to halt or reverse CHF.
- Early intervention is crucial for improving long-term prognosis in heart failure patients.
Abstract:
Chronic heart failure results from two processes, i.e., myocardial and congestive failure. Myocardial failure is clinically silent, most often progresses slowly, and is documented by a depressed left ventricular ejection fraction. Multiple etiologic factors include systolic and diastolic overloads, myocardial necrosis and/or ischemia, and, perhaps, microvascular spasm. Myocardial failure ultimately leads to exaggerated neurohumoral compensatory mechanisms and derangements of the peripheral circulation, which are the hallmarks of congestive heart failure. At that stage of the syndrome, patients have symptoms, initially, with exercise and, later, at rest. Objective assessment of severity is afforded by determination of maximal oxygen uptake during maximal exercise testing. When congestive heart failure supervenes, the prognosis is poor. Current medical therapy is aimed at improving the derangements of the peripheral circulation, which relieves the symptoms but leaves the primary myocardial process unaffected. The goal of future therapy is to intervene at an earlier stage of the syndrome to halt or even partially reverse the myocardial failure.
Related Concept Videos
01:17Pathophysiology of Heart Failure
01:26Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:27Heart Failure I: Introduction
01:29Heart Failure II: Pathophysiology
01:26Heart Failure III: Clinical Manifestations
01:30Cardiomyopathy II: Dilated Cardiomyopathy